Critics charge that, in addition to being slow to recruit patients, the NIH's long Covid initiative is looking at open-ended research questions rather than testing out therapies or treatments.
Critics charge that, in addition to being slow to recruit patients, the NIH's long Covid initiative is looking at open-ended research questions rather than testing out therapies or treatments.